Improvements to Gene Therapy Clinical Trial Design Benefit Hemophilia Patients – Genetic Engineering & Biotechnology News
Genetic Engineering & Biotechnology News |
Improvements to Gene Therapy Clinical Trial Design Benefit Hemophilia Patients
Genetic Engineering & Biotechnology News A new gene therapy trial in hemophilia B patients is the most successful so far, allowing all 10 participants to give up their medication, and 9 out of the 10 to avoid spontaneous bleeding altogether. The participants, all men, saw dramatic increases … |
